Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Usana Health Sciences (USNA) over the last 16 years, with Q3 2025 value amounting to $145.0 million.

  • Usana Health Sciences' Total Liabilities rose 493.2% to $145.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $145.0 million, marking a year-over-year increase of 493.2%. This contributed to the annual value of $161.9 million for FY2024, which is 1940.61% up from last year.
  • Per Usana Health Sciences' latest filing, its Total Liabilities stood at $145.0 million for Q3 2025, which was up 493.2% from $149.0 million recorded in Q2 2025.
  • In the past 5 years, Usana Health Sciences' Total Liabilities registered a high of $199.2 million during Q1 2021, and its lowest value of $119.2 million during Q2 2024.
  • Moreover, its 5-year median value for Total Liabilities was $152.2 million (2022), whereas its average is $155.8 million.
  • As far as peak fluctuations go, Usana Health Sciences' Total Liabilities crashed by 1940.49% in 2022, and later soared by 2586.18% in 2025.
  • Quarter analysis of 5 years shows Usana Health Sciences' Total Liabilities stood at $179.9 million in 2021, then fell by 9.89% to $162.1 million in 2022, then decreased by 16.36% to $135.6 million in 2023, then grew by 19.41% to $161.9 million in 2024, then fell by 10.39% to $145.0 million in 2025.
  • Its Total Liabilities stands at $145.0 million for Q3 2025, versus $149.0 million for Q2 2025 and $162.7 million for Q1 2025.